saxagliptin
Selected indexed studies
- Saxagliptin. (, 2012) [PMID:31643998]
- Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. (N Engl J Med, 2013) [PMID:23992601]
- Saxagliptin/Dapagliflozin: A Review in Type 2 Diabetes Mellitus. (Drugs, 2017) [PMID:28176222]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Saxagliptin. (2012) pubmed
- Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. (2013) pubmed
- Saxagliptin/Dapagliflozin: A Review in Type 2 Diabetes Mellitus. (2017) pubmed
- Saxagliptin. (2006) pubmed
- Saxagliptin: A Review in Type 2 Diabetes. (2015) pubmed
- Efficacy and tolerability of initial triple combination therapy with metformin, dapagliflozin and saxagliptin compared with stepwise add-on therapy in drug-naïve patients with type 2 diabetes (TRIPLE-AXEL study): A multicentre, randomized, 104-week, open-label, active-controlled trial. (2024) pubmed
- Saxagliptin promotes random skin flap survival. (2023) pubmed
- Efficacy and safety of saxagliptin for the treatment of type 2 diabetes mellitus. (2020) pubmed
- Saxagliptin overview: special focus on safety and adverse effects. (2013) pubmed
- Saxagliptin: a clinical review in the treatment of type 2 diabetes mellitus. (2011) pubmed